公开(公告)号：US20200078215A1

公开(公告)日：2020-03-12

申请号：US16315499

申请日：2017-07-05

Applicant: MicroOptx Inc. ,  J. David BROWN ,  Christopher Clark PULLING ,  Roy Christian MARTIN ,  Edward Aaron COHEN

Inventor： J. David Brown ,  Christopher Clark Pulling ,  Roy Christian Martin ,  Edward Aaron Cohen

IPC: A61F9/007 ,  A61F9/013

Abstract: Devices can be implanted in an eye to treat glaucoma and/or dry eye. The devices described herein include a body defining a lumen and having first and second ends and external and lumenal surfaces. The body has a length sufficient to provide fluid communication between the anterior chamber and tear film of the eye through the lumen when the device is implanted in the sclera. The body can include a radiused distal edge. A distal end portion of the body can be laterally flared. The body can include a mid-body portion that is laterally narrower than distal and proximal end portions of the body. Methods of treating glaucoma and/or dry eye, wherein the device is implanted in the sclera of an afflicted eye, are also described.

公开(公告)号：US20220125638A1

公开(公告)日：2022-04-28

申请号：US17569929

申请日：2022-01-06

Applicant: MicroOptx Inc.

Inventor： J. David Brown ,  Christopher Clark Pulling ,  Roy Christian Martin ,  Edward Aaron Cohen

IPC: A61F9/007 ,  A61F9/013

Abstract: Devices can be implanted in an eye to treat glaucoma and/or dry eye. The devices described herein include a body defining a lumen and having first and second ends and external and lumenal surfaces. The body has a length sufficient to provide fluid communication between the anterior chamber and tear film of the eye through the lumen when the device is implanted in the sclera. The body can include a radiused distal edge. A distal end portion of the body can be laterally flared. The body can include a mid-body portion that is laterally narrower than distal and proximal end portions of the body. Methods of treating glaucoma and/or dry eye, wherein the device is implanted in the sclera of an afflicted eye, are also described.

公开(公告)号：US20210219878A1

公开(公告)日：2021-07-22

申请号：US17220791

申请日：2021-04-01

Applicant: MicroOptx Inc.

Inventor： Roy Christian Martin ,  Christopher Clark Pulling ,  Christopher Thomas Martin ,  J. David Brown

IPC: A61B5/145 ,  A61B5/1459 ,  A61B5/1455 ,  A61B5/00

Abstract: A method for monitoring glucose concentration in aqueous humor can include inserting an implantable device into an eye and determining glucose concentration as a function of glucose sensed at the implantable device. The method can optionally include optically detecting glucose concentration as a function of polarimetry and/or fluorescence. A system for monitoring glucose concentration can include devices described herein.

公开(公告)号：US10987033B2

公开(公告)日：2021-04-27

申请号：US15775254

申请日：2016-11-11

Applicant: MicroOptx Inc.

Inventor： Roy Christian Martin ,  Christopher Clark Pulling ,  Christopher Thomas Martin ,  J. David Brown

IPC: A61B5/1455 ,  A61B5/145 ,  A61B5/1459 ,  A61B5/00

Abstract: A method for monitoring glucose concentration in aqueous humor can include inserting an implantable device into an eye and determining glucose concentration as a function of glucose sensed at the implantable device. The method can optionally include optically detecting glucose concentration as a function of polarimetry and/or fluorescence. A system for monitoring glucose concentration can include devices described herein.

公开(公告)号：US20180333085A1

公开(公告)日：2018-11-22

申请号：US15775254

申请日：2016-11-11

Applicant: MicroOptx Inc.

Inventor： Roy Christian Martin ,  Christopher Clark Pulling ,  Christopher Thomas Martin ,  J. David Brown

IPC: A61B5/145 ,  A61B5/1459 ,  A61B5/00

CPC classification number: A61B5/14532 ,  A61B5/14507 ,  A61B5/1455 ,  A61B5/1459 ,  A61B5/6821 ,  A61B5/686

Abstract: A method for monitoring glucose concentration in aqueous humor can include inserting an implantable device into an eye and determining glucose concentration as a function of glucose sensed at the implantable device. The method can optionally include optically detecting glucose concentration as a function of polarimetry and/or fluorescence. A system for monitoring glucose concentration can include devices described herein.